These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25797263)

  • 1. Downregulation of miR-432 activates Wnt/β-catenin signaling and promotes human hepatocellular carcinoma proliferation.
    Jiang N; Chen WJ; Zhang JW; Xu C; Zeng XC; Zhang T; Li Y; Wang GY
    Oncotarget; 2015 Apr; 6(10):7866-79. PubMed ID: 25797263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-557 inhibits hepatocellular carcinoma progression through Wnt/β-catenin signaling pathway by targeting RAB10.
    Cheng X; Wu C; Xu H; Zou R; Li T; Ye S
    Aging (Albany NY); 2024 Feb; 16(4):3716-3733. PubMed ID: 38364252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-29a-SIRT1-Wnt/β-Catenin Axis Regulates Tumor Progression and Survival in Hepatocellular Carcinoma.
    Qian L; Zhang Y; Wang G; Li B; Zhou H; Qiu J; Qin L
    Biochem Genet; 2024 Jun; 62(3):1895-1913. PubMed ID: 37776468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Hydroxytryptamine promotes hepatocellular carcinoma proliferation by influencing β-catenin.
    Fatima S; Shi X; Lin Z; Chen GQ; Pan XH; Wu JC; Ho JW; Lee NP; Gao H; Zhang G; Lu A; Bian ZX
    Mol Oncol; 2016 Feb; 10(2):195-212. PubMed ID: 26474915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 20(S)-Ginsenoside Rh2 inhibits hepatocellular carcinoma by suppressing angiogenesis and the GPC3-mediated Wnt/β‑catenin signaling pathway.
    Xu L; Li J; Hou N; Han F; Sun X; Li Q
    Acta Biochim Biophys Sin (Shanghai); 2024 May; 56(5):688-696. PubMed ID: 38584523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-34a screened by miRNA profiling negatively regulates Wnt/β-catenin signaling pathway in Aflatoxin B1 induced hepatotoxicity.
    Zhu L; Gao J; Huang K; Luo Y; Zhang B; Xu W
    Sci Rep; 2015 Nov; 5():16732. PubMed ID: 26567713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UCHL5 promotes hepatocellular carcinoma progression by promoting glycolysis through activating Wnt/β-catenin pathway.
    Wan B; Cheng M; He T; Zhang L
    BMC Cancer; 2024 May; 24(1):618. PubMed ID: 38773433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stearoyl-CoA Desaturase Promotes Liver Fibrosis and Tumor Development in Mice via a Wnt Positive-Signaling Loop by Stabilization of Low-Density Lipoprotein-Receptor-Related Proteins 5 and 6.
    Lai KKY; Kweon SM; Chi F; Hwang E; Kabe Y; Higashiyama R; Qin L; Yan R; Wu RP; Lai K; Fujii N; French S; Xu J; Wang JY; Murali R; Mishra L; Lee JS; Ntambi JM; Tsukamoto H
    Gastroenterology; 2017 May; 152(6):1477-1491. PubMed ID: 28143772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. lncRNA SNHG7 sponges miR-425 to promote proliferation, migration, and invasion of hepatic carcinoma cells via Wnt/β-catenin/EMT signalling pathway.
    Yao X; Liu C; Liu C; Xi W; Sun S; Gao Z
    Cell Biochem Funct; 2019 Oct; 37(7):525-533. PubMed ID: 31478234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers.
    Carotenuto P; Fassan M; Pandolfo R; Lampis A; Vicentini C; Cascione L; Paulus-Hock V; Boulter L; Guest R; Quagliata L; Hahne JC; Ridgway R; Jamieson T; Athineos D; Veronese A; Visone R; Murgia C; Ferrari G; Guzzardo V; Evans TRJ; MacLeod M; Feng GJ; Dale T; Negrini M; Forbes SJ; Terracciano L; Scarpa A; Patel T; Valeri N; Workman P; Sansom O; Braconi C
    Gut; 2017 Jul; 66(7):1268-1277. PubMed ID: 27618837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RETRACTED: MicroRNA-298 represses hepatocellular carcinoma progression by inhibiting CTNND1-mediated Wnt/β-catenin signaling.
    Cao N; Mu L; Yang W; Liu L; Liang L; Zhang H
    Biomed Pharmacother; 2018 Oct; 106():483-490. PubMed ID: 29990836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiproliferative Effects of Epigenetic Modifier Drugs Through E-cadherin Up-regulation in Liver Cancer Cell Lines.
    Uribe D; Cardona A; Esposti DD; Cros MP; Cuenin C; Herceg Z; Camargo M; Cortés-Mancera FM
    Ann Hepatol; 2018; 17(3):444-460. PubMed ID: 29735783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glypican-3 promotes cell proliferation and tumorigenesis through up-regulation of β-catenin expression in lung squamous cell carcinoma.
    Wang D; Gao Y; Zhang Y; Wang L; Chen G
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31160489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wnt/β-catenin signaling pathway in liver biology and tumorigenesis.
    Matsumoto S; Kikuchi A
    In Vitro Cell Dev Biol Anim; 2024 May; 60(5):466-481. PubMed ID: 38379098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GSTZ1-1 downregulates Wnt/β-catenin signalling in hepatocellular carcinoma cells.
    Lei C; Wang Q; Tang N; Wang K
    FEBS Open Bio; 2020 Jan; 10(1):6-17. PubMed ID: 31782257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aflatoxin B1 negatively regulates Wnt/β-catenin signaling pathway through activating miR-33a.
    Fang Y; Feng Y; Wu T; Srinivas S; Yang W; Fan J; Yang C; Wang S
    PLoS One; 2013; 8(8):e73004. PubMed ID: 24015284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dual roles of circRNAs in Wnt/β-Catenin signaling and cancer progression.
    Almalki WH; Almujri SS
    Pathol Res Pract; 2024 Mar; 255():155132. PubMed ID: 38335783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FAT4 loss initiates hepatocarcinogenesis through the switching of canonical to noncanonical WNT signaling pathways.
    Huang FY; Wong DK; Mak LY; Cheung TT; Zhang SS; Chau HT; Hui RW; Seto WK; Yuen MF
    Hepatol Commun; 2023 Dec; 7(12):. PubMed ID: 38055646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DLK1/DIO3 locus upregulation by a β-catenin-dependent enhancer drives cell proliferation and liver tumorigenesis.
    Sanceau J; Poupel L; Joubel C; Lagoutte I; Caruso S; Pinto S; Desbois-Mouthon C; Godard C; Hamimi A; Montmory E; Dulary C; Chantalat S; Roehrig A; Muret K; Saint-Pierre B; Deleuze JF; Mouillet-Richard S; Forné T; Grosset CF; Zucman-Rossi J; Colnot S; Gougelet A
    Mol Ther; 2024 Apr; 32(4):1125-1143. PubMed ID: 38311851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt signaling in liver cancer.
    Takigawa Y; Brown AM
    Curr Drug Targets; 2008 Nov; 9(11):1013-24. PubMed ID: 18991612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.